| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Western Australia, Australia; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia; Cancer Immunology Program, Sir Donald and Lady Trescowthick Laboratories, Peter MacCallum Cancer Centre, East Melbourne 3002, Victoria, Australia
* To whom correspondence should be addressed. Email: mariapia{at}cyllene.uwa.edu.a.
| Abstract |
|---|
Both innate and adaptive immune responses participate in the control of murine cytomegalovirus (mCMV) infection. In some mouse strains, like BALB/c, the control of infection relies principally on the activities of CD8+ T cells. mCMV-specific CD8+ T cell responses are unusual in that, even after mCMV has been controlled in the periphery, the number of circulating virus-specific CD8+ T cells remains high compared to those observed in other viral infections. To better understand the generation and maintenance of mCMV-specific CD8+ T cell responses, we evaluated how antigen load and effector molecules, such as perforin (Prf) and IFN-
, influence these responses during acute infection in vivo. Viral burden affected the magnitude, but not the early kinetics of antigen-specific CD8+ T cell responses. Similarly, the magnitude of virus-specific CD8+ T cell expansion was affected by Prf and IFN-
, but contraction of antigen-specific responses occurred normally in both Prf and IFN-
deficient mice. These data indicate that control of mCMV-specific CD8+ T cell expansion and contraction is more complex than anticipated and, despite the role of Prf or IFN-
in controlling viral replication, a full program of T cell expansion and contraction can occur in their absence.
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|